The results of the RAZOR trial of robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer show that robotic surgery is noninferior. However, care must be taken before widespread adoption of this modality, as superiority has not yet been established.
This is a preview of subscription content, log in via an institution to check access.
References
Parekh, D. J. et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391, 2525–2536 (2018).
Alfred Witjes, J. et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 71, 462–475 (2017).
Nix, J. et al. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur. Urol. 57, 196–201 (2010).
Khan, M. S. et al. A single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur. Urol. 69, 613–621 (2016).
Bochner, B. H. et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur. Urol. 67, 1042–1050 (2015).
Kretschmer, A. et al. Prognostic features for quality of life after radical cystectomy and orthotopic neobladder. Int. Braz. J. Urol. 42, 1109–1120 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Burkhard, F.C. Is robot-assisted surgery noninferior or real progress?. Nat Rev Urol 15, 728–729 (2018). https://doi.org/10.1038/s41585-018-0101-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-018-0101-2
- Springer Nature Limited